Scinai Immunotherapeutics Ltd. American Depositary Shares (SCNI) Stock Price

SCNIStock

$0.75−94.85%52W

Market Cap$1.02M

P/E0.41x

PEG Ratio—

Div yield—

Beta2.27

SCNI Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-97.17%

Price vs S&P 500 (4W)-54.15%

VGM Score51.52

P/E Ratio (Annual)0.41x

Book Value / Share (Quarterly)$0.01

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-0.00

Price vs S&P 500 (YTD)-101.36%

Gross Margin (TTM)-222.21%

Net Profit Margin (TTM)-297.92%

EPS (TTM)$-0.01

10-Day Avg Trading Volume6.77M

EPS Excl Extra (TTM)$-0.01

EPS (Annual)$-0.01

ROI (Annual)-98.93%

Gross Margin (Annual)-202.29%

Cash / Share (Quarterly)$0.00

P/E Basic Excl Extra (TTM)0.48x

Revenue Growth QoQ (YoY)-40.49%

P/E Normalized (Annual)0.41x

ROA (Last FY)-71.45%

Revenue Growth TTM (YoY)97.04%

EBITD / Share (TTM)$-0.00

ROE (5Y Avg)-62.91%

Operating Margin (TTM)-254.60%

Cash Flow / Share (Annual)$-0.00

P/B Ratio0.04x

P/B Ratio (Quarterly)0.11x

Net Income / Employee (Annual)$-184,600

EV / Revenue (TTM)-0.82x

Net Interest Coverage (TTM)-9.86x

ROA (TTM)-43.54%

EV / EBITDA (TTM)-0.23x

EPS Incl Extra (Annual)$-0.01

Current Ratio (Annual)1.30x

Quick Ratio (Quarterly)1.31x

3-Month Avg Trading Volume1.54M

52-Week Price Return-94.85%

P/E Incl Extra (TTM)0.48x

Revenue / Employee (TTM)$50,200

Tangible BV / Share (Quarterly)$-1.96

P/S Ratio (Annual)0.39x

Asset Turnover (Annual)0.11x

52-Week High$15.65

EPS Excl Extra (Annual)$-0.01

CapEx CAGR (5Y)-57.75%

26-Week Price Return-87.27%

Quick Ratio (Annual)1.25x

13-Week Price Return-69.90%

Total Debt / Equity (Annual)0.04x

Current Ratio (Quarterly)1.56x

Enterprise Value$-1.86M

Asset Turnover (TTM)0.15x

Revenue / Employee (Annual)$29,100

Pretax Margin (Annual)-633.64%

Cash / Share (Annual)$0.00

3-Month Return Std Dev164.31%

Net Income / Employee (TTM)$-149,600

ROE (Last FY)-102.52%

Net Interest Coverage (Annual)-5.88x

EPS Basic Excl Extra (Annual)$-0.01

Receivables Turnover (TTM)21.22x

Total Debt / Equity (Quarterly)0.02x

EPS Incl Extra (TTM)$-0.01

ROI (TTM)-62.22%

P/S Ratio (TTM)0.23x

Revenue / Share (Annual)$0.00

Tangible BV / Share (Annual)$-0.71

Price vs S&P 500 (52W)-110.38%

P/E Ratio (TTM)0.48x

Year-to-Date Return-89.43%

5-Day Price Return-35.14%

EPS Normalized (Annual)$-0.01

ROA (5Y Avg)-26.60%

Net Profit Margin (Annual)-633.64%

Month-to-Date Return-47.01%

EBITD / Share (Annual)$-0.01

Operating Margin (Annual)-575.29%

LT Debt / Equity (Annual)0.04x

ROI (5Y Avg)-37.83%

P/E Excl Extra (TTM)0.48x

LT Debt / Equity (Quarterly)0.02x

EPS Basic Excl Extra (TTM)$-0.01

P/B Ratio (Annual)0.08x

Pretax Margin (TTM)-297.92%

Book Value / Share (Annual)$0.01

Price vs S&P 500 (13W)-72.59%

Beta2.27x

Revenue / Share (TTM)$0.00

ROE (TTM)-63.93%

52-Week Low$0.73

vGradeA

gGradeC

mGradeF

vgmGradeC

SCNI Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q4 2023	May 15, 2024	-$62.00	-$240.00	-287.10%(-$178.00)
Q3 2023	Oct 31, 2023	-$94.00	$80.00	+185.11%(+$174.00)
Q2 2023	Aug 11, 2023	-$91.00	-$120.00	-31.87%(-$29.00)
Q1 2023	May 15, 2023	-$73.00	-$120.00	-64.38%(-$47.00)

SCNI Analyst Recommendations

May 2024

Jun 2024

Jul 2024

Aug 2024

4.14

Industry Peers — Biological Products(186)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth TTM (YoY)	Gross Margin (TTM)	EPS Growth (5Y)	Price
SCNIScinai Immunotherapeutics Ltd. American Depositary Shares	A	C	F	0.2x	97.0%	-222.2%	—	$0.75
AMGNAmgen Inc	D	C	A	6.1x	9.1%	74.3%	2.9%	$432.49
GILDGilead Sciences Inc	C	B	A	6.4x	5.5%	79.6%	133.6%	$156.19
MRNAModerna, Inc. Common Stock	F	C	A	39.1x	-27.6%	36.4%	—	$218.01
ARGXargenx SE American Depositary Shares	D	A	B	6.6x	165.2%	89.8%	—	$819.14
RVMDRevolution Medicines, Inc. Common Stock	F	—	B	3296.2x	—	—	—	$177.96
BIIBBiogen Inc. Common Stock	C	D	A	3.4x	0.3%	74.0%	-18.8%	$232.65
BNTXBioNTech SE American Depositary Share	C	C	C	7.6x	-11.8%	79.2%	—	$87.71
EXELExelixis Inc	C	B	A	6.3x	9.2%	96.5%	31.1%	$62.23
HALOHalozyme Therapeutics, Inc.	D	B	A	8.3x	41.1%	82.4%	22.9%	$121.84
NBIXNeurocrine Biosciences Inc	C	B	B	4.1x	34.4%	98.0%	2.3%	$135.71
TECHBio-Techne Corp.	D	C	B	9.4x	-0.4%	66.2%	6.0%	$72.57
RGENRepligen Corp	F	C	A	14.2x	16.5%	53.8%	-4.9%	$175.42
APGEApogee Therapeutics, Inc. Common Stock	—	—	A	—	—	—	—	$135.07
PCVXVaxcyte, Inc. Common Stock	—	—	B	—	—	—	—	$63.62
IBRXImmunityBio, Inc. Common Stock	F	A	A	58.7x	192.9%	99.3%	—	$9.18
QGENQIAGEN N.V.	C	C	B	4.5x	3.0%	62.5%	4.2%	$46.13
KRYSKrystal Biotech, Inc. Common Stock	D	B	B	21.3x	22.6%	94.6%	—	$316.58
TWSTTwist Bioscience Corporation Common Stock	D	B	A	20.2x	19.2%	52.0%	—	$132.75
KYMRKymera Therapeutics, Inc. Common Stock	F	B	B	83.0x	134.8%	—	—	$104.78
IOVAIovance Biotherapeutics, Inc. Common Stock	D	B	A	19.0x	34.5%	48.4%	—	$13.62
IMVTImmunovant, Inc. Common Stock	—	—	C	—	—	—	—	$26.73
KODKodiak Sciences Inc Common Stock	—	—	A	—	—	—	—	$85.75
CGONCG Oncology, Inc. Common stock	F	A	B	851.8x	1030.3%	-85.2%	—	$59.85
SRRKScholar Rock Holding Corporation Common Stock	F	—	C	102.7x	—	—	—	$39.90
CRSPCRISPR Therapeutics AG	D	B	B	355.6x	-64.8%	—	—	$49.25
ADPTAdaptive Biotechnologies Corporation Common Stock	D	B	B	12.4x	50.1%	75.6%	—	$24.02
RLAYRelay Therapeutics, Inc. Common Stock	F	D	B	344.7x	23.9%	—	—	$16.28
TARSTarsus Pharmaceuticals, Inc. Common Stock	D	A	B	5.5x	105.2%	93.3%	—	$68.07
DNLIDenali Therapeutics Inc. Common Stock	F	—	C	781.1x	—	—	—	$17.61
BEAMBeam Therapeutics Inc. Common Stock	D	B	C	15.5x	158.9%	—	—	$23.47
ADMAADMA Biologics, Inc.	C	C	B	4.7x	8.0%	64.7%	—	$10.68
VCELVericel Corporation	D	B	B	6.7x	22.9%	74.6%	38.9%	$40.13
BCRXBioCryst Pharmaceuticals Inc	B	A	B	2.1x	68.7%	97.8%	—	$7.79
RXRXRecursion Pharmaceuticals, Inc. Class A Common Stock	D	C	C	33.9x	-15.1%	3.5%	—	$3.46
NVAXNovavax Inc	C	D	B	4.5x	-61.6%	79.2%	—	$11.26
ALVOAlvotech Ordinary Shares	D	D	B	3.9x	-12.1%	60.7%	—	$5.00
MESOMesoblast Limited American Depositary Shares	D	A	C	14.6x	599.2%	86.1%	—	$13.28
VIRVir Biotechnology, Inc. Common Stock	B	B	B	5.6x	1496.1%	100.0%	—	$9.96
MAZEMaze Therapeutics, Inc. Common Stock	—	A	B	—	700.0%	—	—	$27.53
IMCRImmunocore Holdings plc American Depositary Shares	D	B	B	3.5x	20.9%	98.9%	—	$29.40
COAGHemab Therapeutics Holdings, Inc. Common Stock	—	—	C	—	—	—	—	$30.07
INBXInhibrx Biosciences, Inc. Common Stock	D	C	A	944.3x	550.0%	—	—	$89.83
TSHATaysha Gene Therapies, Inc. Common Stock	D	C	D	120.7x	-32.3%	—	—	$3.62
IMTXImmatics N.V. Ordinary Shares	C	C	C	21.5x	-68.0%	—	—	$6.73
REPLReplimune Group, Inc.	—	—	B	—	—	—	—	$10.86
VORVor Biopharma Inc. Common Stock	—	—	C	—	—	—	—	$18.03
MGTXMeiraGTx Holdings plc Ordinary Shares	C	A	C	2.2x	948.4%	98.0%	—	$9.28
SLBTSL Science Holding Limited Ordinary Shares	—	—	D	—	—	—	—	$1.53
CGEMCullinan Therapeutics, Inc. Common Stock	—	—	C	—	—	—	—	$12.93
GLUEMonte Rosa Therapeutics, Inc. Common Stock	D	F	D	28.9x	-83.9%	—	—	$9.74

About Scinai Immunotherapeutics Ltd. American Depositary Shares

Scinai Immunotherapeutics operates a diversified biopharmaceutical model combining contract manufacturing services with proprietary drug development. The company's CDMO division provides drug development and GMP manufacturing support to biotech clients, representing the majority of current revenue. In-house, it is developing NanoAbs—nanosized VHH antibodies—targeting inflammation and immunology conditions with significant unmet medical needs.